Dr. Helya Peyman, DO

Dr. Peyman practices at Sharp Tri-City Medical Center in Oceanside, California, part of Sharp HealthCare.

Dr. Peyman's NPI, 1407410731, was assigned on April 22, 2019. Dr. Peyman graduated from Pacific Northwest University of Health Sciences College of Osteopathic Medicine in 2020. Dr. Peyman holds California license 21137.

Dr. Peyman's primary practice is Sharp Tri-City Medical Center, at 4002 Vista Way, Oceanside, CA 92056 in San Diego County. The practice phone is (760) 724-8411.

Dr. Peyman's primary practice is Sharp Tri-City Medical Center in Oceanside, California, part of Sharp HealthCare. Dr. Peyman is also affiliated with Hoag Hospital Newport Beach. The medical group on file is Sound Physicians. Dmand AI also links Dr. Peyman to 2 more medical groups, 1 group practice or clinic and 1 other site, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Peyman practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Peyman's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Peyman is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Peyman's licenses on file in 3 states: California, Washington and Idaho.

Dmand AI lists chronic hypertension, coronary artery disease, high cholesterol, non-alzheimer's dementia (chronic), obesity, osteoporosis and underactive thyroid among the conditions Dr. Peyman treats.

CMS data shows 425 Medicare services from Dr. Peyman across 9 procedure codes in 2024, for 183 Medicare patients. Medicare paid $36,969 for them.

CMS counts 183 Medicare patients who saw Dr. Peyman in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 21% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Peyman's median patient age at 70, with 52% women.

In 2024, Dr. Peyman wrote 1,229 Medicare Part D claims for 208 patients. 89% of them were for generic drugs. CMS names the drug for 850 of them, across 34 drugs with 11 or more claims each, at $88,389 in total drug cost. In 2023, CMS named 130 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Peyman for performance year 2024, reported as part of a group. Dr. Peyman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 7 general payments to Dr. Peyman from 5 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $314.

Dr. Peyman graduated from Pacific Northwest University of Health Sciences College of Osteopathic Medicine in 2020.

Dr. Peyman is in network with 7 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and Elevance. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.